SUBSCRIBE
SUBSCRIBE

Fulcrum Therapeutics

NEWS
Deals
SVB Financial Group to Buy Venture Capital Firm Leerink, a Top 10 Underwriter for Biotech IPOs
Leerink Holdings is the Boston-based parent company of Leerink Partners. Leerink Partners is an investment bank focused on healthcare and life sciences.
November 14, 2018
 · 
2 min read
 · 
Mark Terry
Genetown
Fulcrum Therapeutics Raises $80 Million Series B From Investors, Including Sanofi and Bill Maris’ Section 32
Fulcrum Therapeutics, based in Cambridge, Massachusetts, closed on an $80 million Series B financing.
September 5, 2018
 · 
2 min read
 · 
Mark Terry
Business
The Next Generation: Top 20 Life Science Startups to Watch in 2017
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
January 3, 2017
 · 
11 min read
 · 
Mark Terry
What You Need to Know About Fulcrum Therapeutics
Business
What You Need to Know About Fulcrum Therapeutics
January 3, 2017
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Former Epizyme CEO Helms Fulcrum Therapeutics; New Startup Banks $55 Million Series A
July 19, 2016
 · 
3 min read
Load More
AWARDS
  • NextGen Class of 2017
JOBS
IN THE PRESS
Genetown
Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 6, 2024
 · 
1 min read
Genetown
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 07, 2023
December 7, 2023
 · 
1 min read
Genetown
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 10, 2023
November 10, 2023
 · 
1 min read
Genetown
Fulcrum Therapeutics to Participate at Upcoming November Investor Conferences
November 9, 2023
 · 
1 min read
Business
Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Third Quarter 2023
November 7, 2023
 · 
11 min read
Business
Fulcrum Therapeutics to Host Third Quarter 2023 Financial Results Conference Call and Webcast on Tuesday, November 7, 2023, at 8:00 a.m. ET
October 31, 2023
 · 
1 min read
Genetown
Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference
September 22, 2023
 · 
1 min read
Genetown
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 15, 2023
September 15, 2023
 · 
1 min read
Drug Development
Fulcrum Announces Completion of Enrollment in the Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)
September 7, 2023
 · 
5 min read
Genetown
FDA Lifts Clinical Hold on Fulcrum Therapeutics’ FTX-6058 for Sickle Cell Disease
August 22, 2023
 · 
6 min read
Load More